An assessment of fructose-1,6-bisphosphate as an antimicrobial and anti-inflammatory agent in sepsis

Pharmacological Research

Volumn 47, Issue 1, 2003, Pages 35-41

  Nunes, Fernanda B ^a,b   Graziottin, Cássio M ^a   Alves Filho, José Carlos F ^a   Lunardelli, Adroaldo ^a   Pires, Melissa G S ^a   Wächter, Paulo H ^a   De Oliveira, Jarbas R ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Intercap   (Brazil)

Author keywords

Antimicrobial; Fructose 1,6 bisphosphate; Inflammation; Sepsis

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CALCIUM ION; CARRAGEENAN; FRUCTOSE BISPHOSPHATASE; SUGAR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BLOOD CULTURE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; ESCHERICHIA COLI; FECES; LEUKOCYTE; MALE; NONHUMAN; PERITONEUM; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; RAT STRAIN; SEPSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG EVALUATION, PRECLINICAL; FRUCTOSEDIPHOSPHATES; MALE; RATS; RATS, WISTAR; SEPSIS;

EID: 0037285066     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(02)00255-4     Document Type: Article

References (38)

1. Creteur J., Vicente J.L. Hemoglobin solutions: an "all-in-one" therapeutic strategy in sepsis? Crit. Care Med. 28:2000;894-896.
2. Davies M.G., Hagen P.O. Systemic inflammatory response syndrome. J. Surg. 84:1997;920-935.
3. Groeneveld A.B.C., Kester A.D.M., Nauta J.J.P. Relation of arterial blood lactate to oxygen delivery and hemodynamic variables in human shock states. Circ. Shock. 22:1987;35-53.
4. Metrangolo L., Fiorillo M., Friedman G.et al. Early hemodynamic course of septic shock. Crit. Care Med. 23:1995;1931-1975.
5. Benjamin E., Leibowitz A.B., Oropello J., Iberti T.J. Systemic hypoxic and inflammatory syndrome: an alternative designation for "sepsis syndrome" Crit. Care Med. 20:1992;680-682.
6. Mammen E.F. The haematological manifestation of sepsis. J. Antimicrob. Chemother. 41:1989;17-24.
7. Schweighoffer T., Shaw S. Adhesion cascades: diversity through combinatorial strategies. Curr. Opin. Cell Biol. 4:1992;824-829.
8. Service R.F. Antibiotics that resistence. Science. 270:1995;724-727.
9. Bochud P.Y., Glauser M.P., Calandra T. Antibiotics in sepsis. Intensive Care Med. 27:2001;S33-S48.
10. Markov A.K. Hemodynamics and metabolic effects of fructose-1,6-diphosphate in ischemia and shock - experimental and clinical observations. Ann. Emerg. Med. 15:1986;1470-1477.
11. Vexler Z., Berrios M., Ursell P.C., Sola A., Ferriero D.M., Gregory G.A. Toxicity of fructose-1,6-bisphosphate in developing normoxic rats. Pharmacol. Toxicol. 84:1999;115-121.
12. Kelleher J.A., Chan P.H., Chan T.Y.Y., Gregory G.A. Energy metabolism in hypoxic astrocytes: protective mechanism of fructose-1,6-biphosphate. Neurochem. Res. 20:1995;785-792.
13. Markov A.K., Oglethorpe N.C., Terry J., Grogan J.B., Hellem H.K. Hemodynamic, eletrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia. Am. Heart J. 100:1980;639-646.
14. 4 hepatotoxicity in rats. Biochem. J. 262:1989;721-725.
15. Oliveira J.R., Rosa J.L., Ambrosio S.et al. Effect of galactosamine on hepatic carbohydrate metabolism: protective role of fructose-1,6-bisphosphate. Hepatology. 15:1992;1147-1153.
16. Takeuchi K., Cao-dawh H., Friehs J., Glynn P., D'agostino D., Simplaceanu E.et al. Administration of fructose-1,6-diphosphate during early reperfusion. significantly improves recovery of contractile function in the postischemia heart. J. Thorac. Cardiovasc. Surg. 116:1998;335-343.
17. Herrero I., Torras J., Carrera M., Castells A., Pasto L., Gil-vernet S.et al. Evaluation of a preservation solution containing fructose-1,6-diphosphate and manitol using the isolated perfused rat kidney. Comparison with Euro-Collins and University of Wisconsin Solution. Nephrol. Dial. Transplant. 10:1995;519-526.
18. Farias L.A., Smith E.E., Markov A.K. Preservation of ischemic-hipoxic brain injury and death in rabbits with fructose-1,6-diphosphate. Stroke. 21:1990;606-613.
19. Bickler P.E., Buck L.T. Effects of fructose-1,6-biphosphate on glutamate release and ATP loss from rat brain slices during hypoxia. J. Neurochem. 64:1996;1463-1468.
20. Sun J., Farias L.A., Markov A.K. Fructose-1,6-diphosphate prevents intestinal ischemic reperfusion injury and death in rats. Gastroenterology. 98:1990;117-121.
21. Gregory G.A., Yu A.C.H., Chan P.H. Fructose-1,6-bisphosphate protects astrocytes from hypoxic damage. J. Cereb. Blood Flow Metab. 9:1989;29-34.
22. Klouchek E., Markov M., Popov A. A pharmacological study of the hepatoprotective activity of fructose-1,6-diphosphate. EKSP Med. Morphol. 31:1993;60-71.
23. + permeability in isolated rat hepatocytes. Am. J. Physiol. 273:1997;473-478.
24. Nunes F.B., Oliveira J.R., Pires M.G.S., Wächter P.H. Septic induction in rats (Wistar): experimental model. Revista de Medicina da PUCRS. 10:2000;183-187.
25. Bier O. Microbiologia e imunologia. 24th ed. São Paulo: Melhoramentos; 1985, p. 999-1001.
26. Antunes GS. Manual de diagnóstico bacteriológico. 2nd ed. Porto Alegre: Editora da UFRGS; 1995.
27. Vandepitte J, Engbaek K, Piot P, Heuck CC. Procedimentos laboratoriais em bacteriologia clínica. 2nd ed. São Paulo: Santos; 1997.
28. Nunes F.B., Oliveira J.R. Analysis of rats periferical blood submited to sepsis and treated with fructose-1,6-bisphosphate. Biociências. 6:1998;57-69.
29. Robertson A.B., Schwartz B. Ascorbic acid and the formation of collagen. J. Biol. Chem. 201:1953;689-696.
30. Benitz K.F., Hall L.M. Local morphological response following a single subcutaneous injection of carragenin in the rats. Proc. Soc. Exp. Biol. Med. 102:1959;442-445.
31. Winter C.A., Risley E.A., Nuss G.W. Carrageenan-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:1962;544.
32. Farber J.L., Young E.E. Accelerated phospholipid degradation in anoxic rat hepatocytes. Arch. Biochem. Biophys. 221:1989;312-320.
33. Hassinen I.E., Nuutinen E.M., Ito K., Nioka S., Lazzarino G., Giardina B.et al. Mechanism of the effect of exogenous fructose-1,6-bisphosphate on myocardial energy metabolism. Circulation. 83:1991;584-593.
34. Lazzarino G., Viola A.R., Muliere L., Rotilio G., Mavelli I. Prevention by fructose-1,6-bisphosphate of cardiac oxidative damage induced in mice by subchronic doxorubicin treatment. Cancer Res. 47:1987;6511-6516.
35. Farias L.A., Sun J., Markov A.K. Improved brain metabolism with fructose-1,6-diphosphate during insulin-induced hypoglycemic coma. Am. J. Med. Sci. 296:1989;294-299.
36. Didlake R., Kirchner K.A., Lewin J., Bower J.D., Markov A. Protection from ischemic renal injury by fructose-1,6-diphosphate infusion in the rats. Circ. Shock. 16:1985;205-212.
37. Marchionni N., Conti A., Alfieri W., Bari M., Ferrucci L., Lombardi A.et al. Hemodinamic and electrocardiografic effects on fructose-1,6-diphosphate in acute myocardial infarction. Am. J. Cardiol. 56:1985;266-269.
38. Grandi A.M., Moggia C., Barzuzza F., Venco A., Finardi G. Improved left ventricular function after short-term treatment with fructose-1,6-diphosphate: echocardiografic study in chronic ischemic heart disease and idiopathic dilated cardiomyopathy. Clin. Ther. 10:1988;372-380.